Yilun Chen

Suggest Changes
Learn More
BACKGROUND When receiving immunosuppressive therapy, patients with idiopathic nephrotic syndrome who are also carriers of hepatitis B virus (HBV) surface antigen (HBsAg) are at risk for reactivation(More)
  • 1